MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Invests $1.37 Million in Waters Corporation $WAT

Key Points

• MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH has invested approximately $1.37 million in Waters Corporation, acquiring 3,913 shares during the second quarter.
• Several institutional investors have also recently modified their positions in Waters, with hedge funds owning 94.01% of the stock.
• Waters Corporation reported earnings per share of $2.95 for the last quarter, beating estimates, and has set a guidance range for Q3 2025 earnings at 3.150-3.250 EPS.

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH acquired a new stake in shares of Waters Corporation (NYSE:WAT - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 3,913 shares of the medical instruments supplier's stock, valued at approximately $1,366,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in WAT. Olde Wealth Management LLC purchased a new stake in shares of Waters in the first quarter worth $25,000. Zions Bancorporation National Association UT purchased a new position in shares of Waters during the 1st quarter valued at $28,000. IFP Advisors Inc boosted its holdings in Waters by 118.9% in the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock worth $30,000 after buying an additional 44 shares during the period. Whipplewood Advisors LLC boosted its holdings in Waters by 5,200.0% in the 1st quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier's stock worth $39,000 after buying an additional 104 shares during the period. Finally, Caitong International Asset Management Co. Ltd purchased a new stake in Waters in the 1st quarter worth $41,000. 94.01% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on WAT shares. UBS Group reiterated a "neutral" rating on shares of Waters in a research report on Tuesday, July 15th. Wall Street Zen cut shares of Waters from a "buy" rating to a "hold" rating in a research report on Saturday, July 26th. Jefferies Financial Group set a $385.00 target price on shares of Waters and gave the stock a "buy" rating in a report on Monday, August 4th. Robert W. Baird cut their target price on shares of Waters from $374.00 to $352.00 and set an "outperform" rating for the company in a research note on Wednesday, July 16th. Finally, Deutsche Bank Aktiengesellschaft set a $315.00 price target on shares of Waters and gave the company a "hold" rating in a report on Tuesday, August 5th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $378.73.

Waters Stock Performance

Shares of NYSE:WAT opened at $288.25 on Friday. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $423.56. The company has a market capitalization of $17.16 billion, a price-to-earnings ratio of 25.99, a PEG ratio of 2.73 and a beta of 1.07. The firm's 50-day moving average is $294.98 and its 200 day moving average is $328.37.

Waters (NYSE:WAT - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, beating the consensus estimate of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The firm had revenue of $771.33 million during the quarter, compared to the consensus estimate of $745.96 million. During the same period in the previous year, the company posted $2.63 earnings per share. The firm's quarterly revenue was up 8.8% on a year-over-year basis. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Research analysts predict that Waters Corporation will post 12.86 EPS for the current year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.